logo
Plus   Neg
Share
Email

Ascension Partners With Google On Healthcare Transformation

Ascension said Monday that it is working with Google to optimize the health and wellness of individuals and communities. It aims to deliver a comprehensive portfolio of digital capabilities that enhance the experience of Ascension consumers, patients and clinical providers across the continuum of care.

Earlier today, the Wall Street Journal reported that Google has partnered with one of the country's largest health-care systems to secretly collect and crunch the detailed personal health information of millions of Americans across 21 states. Neither doctors nor patients were made aware of the effort.

The Journal reported that Google began the effort last year with St. Louis-based Ascension, the second-largest health system in the U.S., with the data sharing accelerating since summer.

The data involved in Project Nightingale encompasses lab results, doctor diagnoses and hospitalization records, among other categories, and amounts to a complete health history, including patient names and dates of birth.

At least 150 Google employees already have access to much of the data on tens of millions of patients, the report said.

Meanwhile, Ascension said that it will improve the experience of patients and consumers, as well as providers and associates, and advance its Mission of providing compassionate, personalized care to all, especially people living in poverty and those most vulnerable, through new capabilities.

Ascension said that the collaboration with Google will modernize Ascension's infrastructure by transitioning to the secure, reliable and intelligent Google Cloud Platform.

The collaboration will include transitioning to Google's G Suite productivity and collaboration tools. Using G Suite will enhance Ascension associates' ability to communicate and collaborate securely in real time, supporting interdisciplinary care and operations teams across Ascension sites of care.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients. Ferring Pharmaceuticals US is recalling various nasal sprays citing superpotency or amounts of desmopressin higher than specified, the U.S. Food and Drug Administration announced in a statement. The recall involves all lots on the market of DDAVP Nasal Spray 10 mcg/0.1mL, Desmopressin Acetate Nasal Spray 10 mcg/0.1mL, and STIMATE Nasal Spray 1.5 mg/mL. U.S. President Donald Trump has issued executive orders to ban Chinese mobile application TikTok as well as WeChat, citing a threat to national security and its economy. China's ByteDance Ltd. owns TikTok, a video-sharing mobile app, while Tencent Holdings Ltd. owns WeChat, a messaging, social media, and electronic payment app.
Follow RTT